Genomic profiles of de novo high and low-volume metastatic prostate cancer: Results from a 2-stage feasibility and prevalence study in the STAMPEDE trial
Clare Gilson, Fiona Ingleby, Duncan C. Gilbert, Marina A. Parry, Nafisah B. Atako, Adnan Ali, Alex Hoyle, Noel W. Clarke, Melissa Gannon, Chris Wanstall, Christopher Brawley, Malcolm D. Mason, Zafar Malik, Andrew Simmons, Andrea Loehr, Alison Parry-Jones, Rosalind Eeles, Zsofia Kote-Jarai, Nicholas D. James, Claire AmosMahesh K.B. Parmar, Ruth E. Langley, Matthew R. Sydes, Gerhardt Attard*, Simon Chowdhury
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
25Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Genomic profiles of de novo high and low-volume metastatic prostate cancer: Results from a 2-stage feasibility and prevalence study in the STAMPEDE trial'. Together they form a unique fingerprint.